Company Filing History:
Years Active: 2025
Title: Christopher Daniel Scott: Innovator in Pharmaceutical Chemistry
Introduction
Christopher Daniel Scott is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on dihydroorotate dehydrogenase (DHOD) inhibitors. His research has the potential to impact the treatment of various diseases.
Latest Patents
Christopher holds a patent for "Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor." This patent discloses polymorphs of 3-(2,3,5,6-tetrafluoro-3'-trifluoromethoxy-biphenyl-4-ylcarbamoyl)-thiophene-2-carboxylic acid. The patent also outlines methods for making these polymorphs, as well as pharmaceutical compositions and kits that include them. Furthermore, it describes methods for treating, preventing, or ameliorating diseases or conditions by administering these polymorphs.
Career Highlights
Christopher is currently associated with Kiora Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.
Collaborations
He collaborates with talented professionals in his field, including Stefan Sperl and Lisa Plasser. These partnerships enhance the research and development efforts at Kiora Pharmaceuticals, Inc.
Conclusion
Christopher Daniel Scott is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatment options. His contributions, particularly in the area of DHOD inhibitors, demonstrate his dedication to innovation in healthcare.